Found: 14
Select item for more details and to access through your institution.
Hyponatremia and MAP‐kinase inhibitors in malignant melanoma: Frequency, pathophysiological aspects and clinical consequences.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 326, doi. 10.1111/pcmr.12749
- By:
- Publication type:
- Article
The lncRNA RMEL3 protects immortalized cells from serum withdrawal‐induced growth arrest and promotes melanoma cell proliferation and tumor growth.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 303, doi. 10.1111/pcmr.12751
- By:
- Publication type:
- Article
Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment‐resistant melanoma, colorectal, and lung cancer.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 292, doi. 10.1111/pcmr.12742
- By:
- Publication type:
- Article
A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF<sup>high</sup>/AXL<sup>low</sup> melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 280, doi. 10.1111/pcmr.12741
- By:
- Publication type:
- Article
Pathway dysregulation analysis of the nucleotide excision repair mechanisms reveals it is not a common feature of melanomas.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 336, doi. 10.1111/pcmr.12740
- By:
- Publication type:
- Article
A lentiviral vector‐based insertional mutagenesis screen identifies mechanisms of resistance to MAPK inhibitors in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 332, doi. 10.1111/pcmr.12737
- By:
- Publication type:
- Article
MC1R CpG island regulates MC1R expression and is methylated in a subset of melanoma tumours.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 320, doi. 10.1111/pcmr.12739
- By:
- Publication type:
- Article
The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 269, doi. 10.1111/pcmr.12735
- By:
- Publication type:
- Article
Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 237, doi. 10.1111/pcmr.12736
- By:
- Publication type:
- Article
In vitro behavior and UV response of melanocytes derived from carriers of CDKN2A mutations and MC1R variants.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 259, doi. 10.1111/pcmr.12732
- By:
- Publication type:
- Article
Development and validation of the Vitiligo Extent Score for a Target Area (VESTA) to assess the treatment response of a target lesion.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 315, doi. 10.1111/pcmr.12730
- By:
- Publication type:
- Article
Analysis of the putative tumor suppressor gene cdkn2ab in pigment cells and melanoma of Xiphophorus and medaka.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 248, doi. 10.1111/pcmr.12729
- By:
- Publication type:
- Article
MITF and UV responses in skin: From pigmentation to addiction.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 224, doi. 10.1111/pcmr.12726
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 2, p. 219, doi. 10.1111/pcmr.12715
- Publication type:
- Article